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Purpose
Juvenile spondyloarthritis (JSpA), referred to as enthesitis-
related arthritis (ERA) sub-type under the International
League of Associations for Rheumatology (ILAR) classifi-
cation of juvenile idiopathic arthritis (JIA), is characterized
by inflammation in the joints and entheses. Axial involve-
ment is uncommon at presentation but may develop in
the second decade of life. Several instruments assessing
disease activity in ankylosing spondylitis have been vali-
dated including the BASDAI and BASFI. At this time,
there are no disease activity scores for JSpA or ERA. The
objective of this study is to measure the intra-rater reliabil-
ity of the BASDAI and the BASFI in JSpA/ERA.
Methods
Patients diagnosed with ERA (ILAR criteria) and followed
at The Hospital for Sick Children Spondyloarthritis Clinic
were included in this study. Patients were excluded if they
were unable to understand, speak or write English, if they
were less than 6 years of age or greater than 18 years of
age. Prospective subjects were consecutively enrolled (June
2009 to June 2010) and, the patient and/or one parent
completed the BASDAI and BASFI at baseline and 2
weeks later (a period during which little change is
expected). Intra-class correlation coefficient (ICC) was
calculated and values greater than 0.6 were considered
indicative of good reliability.
Results
Forty-eight patients (39 males, 81.2%) were enrolled. The
average age at diagnosis was 12.5 years (range, 7.6 to 16.7
years). 41.7% were HLA-B27 positive and 18.8% had a
positive family history for ankylosing spondylitis. 52% had
involvement of the hip and 40% had radiographic evidence
of sacroiliitis. Eight patients dropped out or were excluded
due to protocol violation. 40 patients completed both sets
of questionnaires. All subjects reported their overall health
as “the same” when compared to their baseline visit. The
mean BASDAI at baseline was 1.97 ± 1.90 and at 2 weeks
was 1.69 ± 1.80 – the reliability was substantial; ICC =
0.74, Bland-Altman limits of agreement (LOA) = 2.4 to
-2.8. The mean BASFI at baseline was 0.99 ± 1.49 and at 2
weeks was 0.75 ± 1.00 – likewise the reliability was excel-
lent; ICC = 0.87, Bland-Altman LOA = 1.1 to -1.4. When
examining individual questions from the BASDAI and
BASFI, the following had the highest ICCs, respectively:
“How long does your morning stiffness last from the time
you wake up?” and “Doing a full day’s activities, whether it
be at home or at work”, ICC = 0.88 each. Meanwhile,
from the BASDAI, “How would you describe the overall
level of AS neck, back or hip pain you have had?” resulted
in the lowest reliability; ICC = 0.57.
Conclusion
At this time, there is no validated disease activity score for
JSpA/ERA. Both the BASDAI and BASFI showed excellent
intra-rater reliability in a cohort of ERA patients. Next
steps will include the measurement of the construct valid-
ity and responsiveness of these tools in JSpA/ERA in order
to determine if pediatric rheumatologists can use these asThe Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
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validated disease activity/functional impairment measures
in the clinic and in clinical research.
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